{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:24:59Z","timestamp":1772119499055,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP17K10154"],"award-info":[{"award-number":["JP17K10154"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Showa University Research Grant for Young Researchers in 2017"},{"name":"Showa University Research Grant for Young Researchers in 2019"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Serum adiponectin circulates in three multimeric isoforms: high-molecular-weight (HMW), middle-molecular-weight (MMW), and low-molecular-weight (LMW) isoforms. Potential change in the circulating adiponectin levels in patients with nephrotic syndrome (NS) remain unknown. This study aimed to assess the levels of total adiponectin and the distribution of its isoforms in pediatric patients with NS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We sequentially measured total adiponectin and each adiponectin isoform levels at the onset of NS, initial remission, and during the remission period of the disease in 31 NS patients. We also calculated the ratios of HMW (%HMW), MMW (%MMW), and LMW (%LMW) to total adiponectin incuding 51 control subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median of total serum adiponectin levels in patients were 36.7, 36.7, and 20.2\u00a0\u03bcg\/mL at the onset, at initial remission, and during the remission period of NS, respectively. These values were significantly higher than those in control subjects. The median values of %HMW, %MMW, and %LMW values were 56.9\/27.0\/14.1 at the onset, 62.0\/21.8\/13.4 at the initial remission, and 58.1\/21.7\/17.5 at during the remission period of NS, respectively. Compared with control subjects, %HMW at initial remission and %MMW at the onset were high, and the %LMW values at the onset and at initial remission were low.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with NS, total serum adiponectin levels increase at the onset of the disease, and the ratio of adiponectin isoforms changes during the course of the disease. Further studies are needed to delineate the mechanisms between proteinuria and adiponectin isoforms change.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10157-021-02085-w","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T05:17:32Z","timestamp":1622524652000},"page":"1027-1034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome"],"prefix":"10.1007","volume":"25","author":[{"given":"Tetsuro","family":"Tamai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Kamijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-8200","authenticated-orcid":false,"given":"Yoshifusa","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Hibino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Nimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsutoshi","family":"Shiratori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushige","family":"Dobashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Itabashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"issue":"1","key":"2085_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1755-5922.2008.00069.x","volume":"27","author":"Y Sun","year":"2009","unstructured":"Sun Y, Xun K, Wang C, Zhao H, Bi H, Chen X, Wang Y. Adiponectin, an unlocking adipocytokine. Cardiovasc Ther. 2009;27(1):59\u201375.","journal-title":"Cardiovasc Ther"},{"key":"2085_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1475-2840-13-103","volume":"13","author":"EZ Fisman","year":"2014","unstructured":"Fisman EZ, Tenenbaum A. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovasc Diabetol. 2014;13:103.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"2085_CR3","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","volume":"86","author":"C Weyer","year":"2001","unstructured":"Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2085_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1530\/EJE-09-1003","volume":"162","author":"S Tenhola","year":"2010","unstructured":"Tenhola S, Todorova B, Jaaskelainen J, Janne OA, Raivio T, Voutilainen R. Serum glucocorticoids and adiponectin associate with insulin resistance in children born small for gestational age. Eur J Endocrinol. 2010;162(3):551\u20137.","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2085_CR5","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1080\/08035250600609799","volume":"95","author":"S Takeshita","year":"2006","unstructured":"Takeshita S, Takabayashi H, Yoshida N. Circulating adiponectin levels in Kawasaki disease. Acta Paediatr. 2006;95(10):1312\u20134.","journal-title":"Acta Paediatr"},{"issue":"10","key":"2085_CR6","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1210\/jc.2002-020694","volume":"87","author":"N Stefan","year":"2002","unstructured":"Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab. 2002;87(10):4652\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2085_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ki.2009.137","volume":"76","author":"K Sharma","year":"2009","unstructured":"Sharma K. The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney Int. 2009;76(2):145\u20138.","journal-title":"Kidney Int"},{"issue":"5","key":"2085_CR8","first-page":"1645","volume":"118","author":"K Sharma","year":"2008","unstructured":"Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest. 2008;118(5):1645\u201356.","journal-title":"J Clin Invest"},{"issue":"10","key":"2085_CR9","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.biochi.2012.02.024","volume":"94","author":"T Jia","year":"2012","unstructured":"Jia T, Carrero JJ, Lindholm B, Stenvinkel P. The complex role of adiponectin in chronic kidney disease. Biochimie. 2012;94(10):2150\u20136.","journal-title":"Biochimie"},{"issue":"1","key":"2085_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1681\/ASN.V131134","volume":"13","author":"C Zoccali","year":"2002","unstructured":"Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002;13(1):134\u201341.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2085_CR11","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00467-015-3146-y","volume":"30","author":"CB Sethna","year":"2015","unstructured":"Sethna CB, Boone V, Kwok J, Jun D, Trachtman H. Adiponectin in children and young adults with focal segmental glomerulosclerosis. Pediatr Nephrol. 2015;30(11):1977\u201385.","journal-title":"Pediatr Nephrol"},{"key":"2085_CR12","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1046\/j.1523-1755.63.s84.49.x","volume":"84","author":"C Zoccali","year":"2003","unstructured":"Zoccali C, Mallamaci F, Panuccio V, Tripepi G, Cutrupi S, Parlongo S, Catalano F, Tanaka S, Ouchi N, Kihara S, et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int Suppl. 2003;84:S98-102.","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"2085_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s00467-004-1770-z","volume":"20","author":"SA Bakkaloglu","year":"2005","unstructured":"Bakkaloglu SA, Soylemezoglu O, Buyan N, Funahashi T, Elhan AH, Peru H, Fidan K, Yilmaz S, Hasanoglu E. High serum adiponectin levels during steroid-responsive nephrotic syndrome relapse. Pediatr Nephrol. 2005;20(4):474\u20137.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2085_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ekir.2019.09.009","volume":"5","author":"S Agrawal","year":"2020","unstructured":"Agrawal S, Merchant ML, Kino J, Li M, Wilkey DW, Gaweda AE, Brier ME, Chanley MA, Gooding JR, Sumner SJ, et al. Predicting and defining steroid resistance in pediatric nephrotic syndrome using plasma proteomics. Kidney Int Rep. 2020;5(1):66\u201380.","journal-title":"Kidney Int Rep"},{"key":"2085_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fendo.2011.00062","volume":"2","author":"K Dadson","year":"2011","unstructured":"Dadson K, Liu Y, Sweeney G. Adiponectin action: a combination of endocrine and autocrine\/paracrine effects. Front Endocrinol (Lausanne). 2011;2:62.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2085_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2174\/187152908783884920","volume":"8","author":"J Beltowski","year":"2008","unstructured":"Beltowski J, Jamroz-Wisniewska A, Widomska S. Adiponectin and its role in cardiovascular diseases. Cardiovasc Hematol Disord Drug Targets. 2008;8(1):7\u201346.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"3","key":"2085_CR17","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1042\/BJ20071492","volume":"409","author":"Y Wang","year":"2008","unstructured":"Wang Y, Lam KS, Yau MH, Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J. 2008;409(3):623\u201333.","journal-title":"Biochem J"},{"issue":"1\u20132","key":"2085_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cca.2006.03.014","volume":"372","author":"H Ebinuma","year":"2006","unstructured":"Ebinuma H, Miyazaki O, Yago H, Hara K, Yamauchi T, Kadowaki T. A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin Chim Acta. 2006;372(1\u20132):47\u201353.","journal-title":"Clin Chim Acta"},{"issue":"12","key":"2085_CR19","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1210\/jc.2006-1051","volume":"91","author":"S Araki","year":"2006","unstructured":"Araki S, Dobashi K, Kubo K, Asayama K, Shirahata A. High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. J Clin Endocrinol Metab. 2006;91(12):5113\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2085_CR20","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2337\/dc05-1801","volume":"29","author":"K Hara","year":"2006","unstructured":"Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006;29(6):1357\u201362.","journal-title":"Diabetes Care"},{"issue":"1","key":"2085_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10157-014-1030-x","volume":"19","author":"K Ishikura","year":"2015","unstructured":"Ishikura K, Matsumoto S, Sako M, Tsuruga K, Nakanishi K, Kamei K, Saito H, Fujinaga S, Hamasaki Y, Chikamoto H, et al. Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. Clin Exp Nephrol. 2015;19(1):6\u201333.","journal-title":"Clin Exp Nephrol"},{"issue":"12","key":"2085_CR22","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.amjcard.2006.07.039","volume":"98","author":"Y Iwashima","year":"2006","unstructured":"Iwashima Y, Horio T, Kumada M, Suzuki Y, Kihara S, Rakugi H, Kawano Y, Funahashi T, Ogihara T. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol. 2006;98(12):1603\u20138.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2085_CR23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1523-1755.2004.00370.x","volume":"65","author":"P Stenvinkel","year":"2004","unstructured":"Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimburger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S, Schalling M, et al. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int. 2004;65(1):274\u201381.","journal-title":"Kidney Int"},{"issue":"9","key":"2085_CR24","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.2337\/db09-0204","volume":"58","author":"M von Eynatten","year":"2009","unstructured":"von Eynatten M, Liu D, Hock C, Oikonomou D, Baumann M, Allolio B, Korosoglou G, Morcos M, Campean V, Amann K, et al. Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes. 2009;58(9):2093\u20139.","journal-title":"Diabetes"},{"issue":"5","key":"2085_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1440-1797.2008.00949.x","volume":"13","author":"YY Shen","year":"2008","unstructured":"Shen YY, Hughes JT, Charlesworth JA, Kelly JJ, Peake PW. Adiponectin is present in the urine in its native conformation, and specifically reduces the secretion of MCP-1 by proximal tubular cells. Nephrology (Carlton). 2008;13(5):405\u201310.","journal-title":"Nephrology (Carlton)"},{"key":"2085_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1475-2840-12-137","volume":"12","author":"WS Jeon","year":"2013","unstructured":"Jeon WS, Park JW, Lee N, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY, Youn BS. Urinary adiponectin concentration is positively associated with micro- and macro-vascular complications. Cardiovasc Diabetol. 2013;12:137.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"2085_CR27","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1089\/chi.2016.0135","volume":"12","author":"R Nishimura","year":"2016","unstructured":"Nishimura R, Sano H, Shirasawa T, Matsudaira T, Miyashita Y, Ochiai H, Kokaze A, Tajima N, Utsunomiya K. Changes in the composition of adiponectin fractions over a 3-year period in children: a population-based cohort study. Child Obes. 2016;12(6):440\u20135.","journal-title":"Child Obes"},{"issue":"13","key":"2085_CR28","doi-asserted-by":"publisher","first-page":"12152","DOI":"10.1074\/jbc.M311113200","volume":"279","author":"UB Pajvani","year":"2004","unstructured":"Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004;279(13):12152\u201362.","journal-title":"J Biol Chem"},{"issue":"2","key":"2085_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/oby.20553","volume":"22","author":"M Goto","year":"2014","unstructured":"Goto M, Goto A, Morita A, Deura K, Sasaki S, Aiba N, Shimbo T, Terauchi Y, Miyachi M, Noda M, et al. Low-molecular-weight adiponectin and high-molecular-weight adiponectin levels in relation to diabetes. Obesity (Silver Spring). 2014;22(2):401\u20137.","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"2085_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/eje.0.1500339","volume":"150","author":"F Fallo","year":"2004","unstructured":"Fallo F, Scarda A, Sonino N, Paoletta A, Boscaro M, Pagano C, Federspil G, Vettor R. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing\u2019s syndrome. Eur J Endocrinol. 2004;150(3):339\u201344.","journal-title":"Eur J Endocrinol"},{"issue":"30","key":"2085_CR31","first-page":"35","volume":"58","author":"RD Lele","year":"2010","unstructured":"Lele RD. Pro-insulin, C peptide, glucagon, adiponectin, TNF alpha, AMPK: neglected players in type 2 diabetes mellitus. J Assoc Physicians India. 2010;58(30):35\u201340.","journal-title":"J Assoc Physicians India"},{"issue":"12","key":"2085_CR32","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1093\/ndt\/gfl423","volume":"21","author":"HA Uchida","year":"2006","unstructured":"Uchida HA, Nakamura Y, Kaihara M, Norii H, Hanayama Y, Sugiyama H, Maeshima Y, Yamasaki Y, Makino H. Steroid pulse therapy impaired endothelial function while increasing plasma high molecule adiponectin concentration in patients with IgA nephropathy. Nephrol Dial Transplant. 2006;21(12):3475\u201380.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2085_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2220\/biomedres.37.215","volume":"37","author":"T Fukushima","year":"2016","unstructured":"Fukushima T, Hozumi A, Tomita M, Yonekura A, Miyata N, Miyamoto T, Taguchi K, Goto H, Tsuda K, Osaki M. Steroid changes adipokine concentration in the blood and bone marrow fluid. Biomed Res. 2016;37(3):215\u201320.","journal-title":"Biomed Res"},{"key":"2085_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jns.2017.08.3250","volume":"381","author":"NFT Braz","year":"2017","unstructured":"Braz NFT, Rocha NP, Vieira ELM, Gomez RS, Kakehasi AM, Teixeira AL. Body composition and adipokines plasma levels in patients with myasthenia gravis treated with high cumulative glucocorticoid dose. J Neurol Sci. 2017;381:169\u201375.","journal-title":"J Neurol Sci"},{"key":"2085_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/B978-0-12-398313-8.00007-5","volume":"90","author":"S Sukumaran","year":"2012","unstructured":"Sukumaran S, Jusko WJ, DuBois DC, Almon RR. Glucocorticoid effects on adiponectin expression. Vitam Horm. 2012;90:163\u201386.","journal-title":"Vitam Horm"},{"issue":"2","key":"2085_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/JOE-16-0363","volume":"234","author":"TQ Dang","year":"2017","unstructured":"Dang TQ, Yoon N, Chasiotis H, Dunford EC, Feng Q, He P, Riddell MC, Kelly SP, Sweeney G. Transendothelial movement of adiponectin is restricted by glucocorticoids. J Endocrinol. 2017;234(2):101\u201314.","journal-title":"J Endocrinol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-021-02085-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T06:21:04Z","timestamp":1628662864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-021-02085-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2085"],"URL":"https:\/\/doi.org\/10.1007\/s10157-021-02085-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-28091\/v1","asserted-by":"object"}]},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"assertion":[{"value":"31 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of the Showa University School of Medicine (No. 759, No. 20T5017, No. 3387).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"An informed written consent was obtained from either one or both parents of each child before the enrollment in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}